ELLEN PORTER: Open Payments
NPI 1881625705 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 37 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $900 · 2025 $829
Food & beverage: $820Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $192 |
| Ipsen Biopharmaceuticals, Inc | 2 | $161 |
| Janssen Biotech, Inc. | 8 | $142 |
| Ardelyx, Inc. | 3 | $106 |
| Phathom Pharmaceuticals, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| GENZYME CORPORATION | 1 | $39 |
| PFIZER INC. | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: IQIRVO, TREMFYA, RINVOQ, IBSRELA, VOQUEZNA, ENTYVIO, SKYRIZI, DUPIXENT.
Industry payments across LA — which companies pay providers there.
